BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://github.com/derhansen/sf_event_mgt
METHOD:PUBLISH
BEGIN:VEVENT
UID:797-96@www.leopoldina.org
CLASS: PUBLIC
SUMMARY:CRISPR-Cas9: A Game Changer in Genome Engineering: Origins and Over
 view
DESCRIPTION:CRISPR-Cas9 is originally an immune system that allows bacteria
  to protect themselves against invasion by mobile genetic elements. Deciphe
 ring the details of the CRISPR-Cas9 mechanism has resulted in the developme
 nt of an RNA-programmable transformative technology in biological sciences,
  allowing rapid and efficient targeted genome engineering in a large variet
 y of cells and organisms.\n\nCRISPR-Cas9 research is now considered as the 
 most dynamic and fastest-moving field in life sciences and holds great prom
 ise for biotechnological and biomedical applications. Already, the CRISPR-C
 as9 system is an integral and critical part of the toolbox for any research
 er who intends to manipulate genetic information by means of targeted intro
 duction or correction of mutations, replacement of genes, modification of D
 NA, chromosomal marking or modulation of transcription in any cell or organ
 ism – and the applications of this breakthrough technology are continuing t
 o increase at a rapid pace.\n\nThe Leopoldina Lecture will be given by Leop
 oldina member Prof. Dr. Emmanuelle Charpentier, Berlin. Dr. Charpentier is 
 a French microbiologist, biochemist and geneticist. Currently, she is Direc
 tor at the Max Planck Institute for Infection Biology in Berlin, Alexander 
 von Humboldt Professor, Professor at Humboldt University and Visiting Profe
 ssor at Umeå University, Sweden. Dr. Charpentier is an expert in regulatory
  mechanisms underlying processes of infection and immunity in bacterial pat
 hogens. With her recent groundbreaking findings in the field of RNA-mediate
 d regulation based on the CRISPR-Cas9 system, she has laid the foundation f
 or the development of a novel, highly versatile and specific genome editing
  technology that is revolutionizing life sciences research and could open u
 p whole new opportunities in biomedical gene therapies.\n\nThe Leopoldina L
 ecture is part of the symposium “Genome Editing in Germany and Korea”, join
 tly organised by the German National Academy of Sciences Leopoldina and the
  Korean Academy of Science and Technology (KAST), which will be held in Ber
 lin, September 19-20.\n\nPicture: Hallbauer&Fioretti\n\nRegistration\n\nReg
 istration is closed.\n\nContact\n\nDr. Ruth NarmannDeputy Head Internationa
 l Relations DepartmentTel.: +49 (0)345 - 47 239 - 835email: ruth.narmann@le
 opoldina.org
LOCATION:Berlin
DTSTAMP:20251112T170935Z
DTSTART:20160919T160000Z
DTEND:19700101T183000Z
END:VEVENT
END:VCALENDAR